Revolution Medicines, Inc. is 22.1x more valuable than Vir Biotechnology, Inc. by market capitalization ($30.65 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VIR | RVMD |
|---|---|---|
| Market cap | $1.39 B | $30.65 B |
| US-listed rank | #2396 | #454 |
| Revenue (latest FY) | $68.56M | $0.00 |
| Net income (latest FY) | -$437.99M | -$1.13B |
| Net margin | -638.9% | - |
| SEC filings | 762 | 782 |
Revolution Medicines, Inc. is 22.1x more valuable than Vir Biotechnology, Inc. by market capitalization ($30.65 B vs $1.39 B).
In their latest fiscal years, Vir Biotechnology, Inc. reported $68.56M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Vir Biotechnology, Inc. and Revolution Medicines, Inc., or browse the full rankings.